Regeneration therapy for diabetes mellitus

Area of Science:

• Biomedical Engineering
• Endocrinology
• Regenerative Medicine

Background:

• Diabetes mellitus, particularly Type 1 and Type 2, is a chronic metabolic disorder characterized by impaired insulin production or function.
• Pancreatic beta-cells are crucial for glucose homeostasis, and their dysfunction or loss leads to hyperglycemia.
• Current treatments manage symptoms but do not offer a definitive cure, highlighting the need for regenerative approaches.

Purpose of the Study:

• To categorize and review current regeneration therapy strategies for pancreatic beta-cells.
• To explore the potential of different cell sources and methods for beta-cell regeneration.
• To discuss the combination of regeneration therapy with other treatment modalities for enhanced efficacy.

Main Methods:

• Classification of regeneration therapy into in vitro, ex vivo, and in vivo approaches.
• Review of cell sources including embryonic stem cells, pancreatic precursor cells, beta-cell lines, and bone marrow stem cells.
• Discussion of therapeutic combinations such as islet transplantation, cell-based therapy, gene therapy, and drug therapy.

Main Results:

• In vitro therapy utilizes cultured cells with immunosuppression or immunoisolation for Type 1 diabetes.
• Ex vivo therapy involves in vitro differentiation of patient's cells (e.g., bone marrow stem cells) into beta-cells, though currently limited.
• In vivo therapy focuses on endogenous beta-cell regeneration (neogenesis and proliferation) for Type 2 diabetes.

Conclusions:

• Regeneration therapy presents diverse strategies for restoring beta-cell function in diabetes.
• While promising, challenges remain, particularly in generating functional insulin-producing cells from certain sources like bone marrow stem cells.
• Combining regeneration therapy with other treatments holds potential for a future cure for diabetes.